source
- GE HealthCare eyes $1 billion purchase of radiopharmaceutical developer Sofie BiosciencesGE HealthCare is reported to be weighing a purchase of Sofie Biosciences, a radiopharmaceutical developer, for as much as $1 billion, according to the Financial Times. Sofie Biosciences, based in…
- STAT+: Trump’s secretive pharma deals may undermine ‘most-favored nation’ pricing, an analysis suggestsThe projected savings from Trump's "most-favored nation" pricing policy might be drastically reduced by secretive deals with pharma companies, a new analysis finds.STAT · 49m ago↗ source